Dr. John Cush RheumNow
4 years 5 months ago
COVID-19 Vaccination Uptake and Perceptions in Rheumatic Patients
Putman et al has reported vaccine survey results from the C19-GRA in Lancet Rheumatology showing the uptake and vaccine hesitancy among people with rheumatic diseases (RMD).
https://t.co/fIHAhpvVho https://t.co/6tFbQd0vJQ
Dr. Jack Cush discusses the news and recent journal reports from last weeks RheumNow.com, and answers viewer questions from #ACA - Ask Cush Anything.
Dr. John Cush RheumNow
4 years 5 months ago
Taiwan claims data shows among 2050 new SLE, 783 on HCQ. HCQ had no effect on future development of CKD over 14 yrs. Yet some rec HCQ in all lupus nephritis to reduce kidney flares, ESKD and death. https://t.co/JS0ST1W0LW https://t.co/ihQp3d5rcy
Dr. John Cush RheumNow
4 years 5 months ago
Mark your calendars for our next Tuesday Night Rheumatology on 4/26 at 7pm!
Speakers will include:
Dr. Eric Ruderman
Dr. Arthur Kavanaugh
Dr. David Liew
Dr. Jack Cush
https://t.co/EqmilGRg5s
You can also find us LIVE on YouTube, Twitter, and Facebook. https://t.co/oW9zl1HudB
Dr. John Cush RheumNow
4 years 5 months ago
Download our newest set of slides on severe Psoriasis.
https://t.co/2j5Sp5IAgp https://t.co/QWUFcuu219
Dr. John Cush RheumNow
4 years 5 months ago
Open label, RCT compared triple DMARD Rx adding either LEF (MLH) or SSZ (MSH) to MTX+HCQ in 136 RA pts. Both were equally effective (non-inferior), 61.7% & 64.7% patients (p = 0.8) at wk 24. AE were also equal (15 vs 21 AE). https://t.co/fdPlMaTAyd
Putman et al has reported vaccine survey results from the COVID-19 Global Rheumatology Alliance (C19-GRA) in Lancet Rheumatology showing the uptake and vaccine hesitancy among people with rheumatic diseases (RMD).
Survey data from 7005 vaccinated and unvaccinated, adult RMD respondents from 102 countries was analyzed.
A single dose of the monoclonal-antibody AZD7442 (combination of tixagevimab and cilgavimab) has been shown to be safe and effective as prophylaxis against COVID-19 infection in high risk individuals who tested positive for COVID-19.
Both MAbs are neutralizing antibodies against SARS-CoV-2 that have and prolonged half-life of approximately 90 days.
Dr. John Cush RheumNow
4 years 5 months ago
QD Clinic - PsA lessons and cases from the Rheumatology clinic.
Distinguishing Psoriatic arthritis from Erosive Osteoarthritis can be difficult
https://t.co/lrLdFszHR0 https://t.co/HaAZ820UfP
Dr. John Cush RheumNow
4 years 5 months ago
UK drug safety warning, observational data 2700 pregnancies, 1st trimester pregabalin (Lyrica) use was assoc w/ higher rate of congenital malformations (5.9 vs 4.1%). US PI label says Lyrica use in Pregnancy "May cause fetal harm". https://t.co/GdIitpe8KW
Held on April 19, 2022, Tuesday Night Rheumatology: Controversies in PsA, featured a lively and informative panel discussion, moderated by Dr. Jack Cush.
The PsA Expert panelists included:
Dr. Dafna Gladman, Toronton
Dr. Joseph Merola, Boston
Dr. Peter Nash, Brisbane
Dr. Christopher Ritchlin, Rochester
Dr. Jose Scher, New York
